Table 2 Pre-operative versus reviewed post-operative endometrial histopathology and FIGO staging
Pre-operative | Revision | Post-operative | Revision | |
|---|---|---|---|---|
Histology and grade (%) | N = 116 | N = 116 | ||
Atrophy/dp | 0 | 2 | 6 | 3 (2.6) |
Hyperplasia | 0 | 0 | 5 | 4 (3.5) |
AH | 45 (38.8) | 36 | 24 | 26 (22.4) |
EEC G1 | 41 (35.4) | 51 | 48 | 55 (47.4) |
G2 | 30 (25.7) | 27 | 28 | 22 (19.0) |
G3 | 0 | 0 | 1 | 2 (1.7) |
Clear cell G3 | 0 | 0 | 1 | 1 (0.9) |
Mixed G3 | 0 | 0 | 1 | 1 (0.9) |
* | 0 | 0 | 1 | 1 (0.9) |
# | 0 | 0 | 1 | 1 (0.9) |
Myometrial invasion if endometrial carcinoma present | N = 81 | |||
No invasion | 19 (23.5) | |||
<½ | 36 (44.4) | |||
>½ | 26 (32.1) | |||
FIGO stage after revision of endometrial hysterectomy specimens | N = 81 | |||
IA | 54 | |||
G1 | 43 | |||
G2 | 9 | |||
G3 | 2 | |||
IB | 22 | |||
G1 | 15 | |||
G2 | 6 | |||
G3 | 1 | |||
II | 2 | |||
G1 | 2 | |||
III | 3 | |||
A G1 | 1 | |||
A G2 | 1 | |||
C2G3 | 1 | |||